HKEX: 1477 - Ocumension Therapeutics

Yield per half year: -32.38%
Sector: Healthcare

Reporting Ocumension Therapeutics

Reports

IFRS
Reporting Annual Quarterly
2020 2021 2022 2023
Финансовый отчет link link link link


Capitalization

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Капитализация, млрд ¥
15.21 14.71 7.36 5.9 6.38
Выручка, млрд ¥
0.00019 0.0131 0.0561 0.159 0.2464 0.2464
Чистая прибыль, млрд ¥
-0.2076 -1.31 -2.26 -0.26 -0.4026 -0.3798 -0.3798
EV, млрд ¥
5.01
EBIT, млрд ¥
-0.0593 -0.1589 -0.4517 -0.3859 -0.4559
EBITDA, млрд ¥
-0.2093 -1.32 -2.26 -0.2594 -0.36 -0.386
Баланс стоимость, млрд ¥
-0.8211 -2.07 2.5 3.11 2.75 2.92 2.92
FCF, млрд ¥
-0.0436 -0.1089 -0.5172 -0.8617 -0.5107 -0.5398 -0.5398
Операционный денежный поток, млрд ¥
-0.052 -0.1081 -0.2126 -0.1968 -0.2007 -0.1779 -0.1779
Операционная прибыль, млрд ¥
-0.2094 -1.33 -0.4878 -0.2461 -0.4004 -0.4013 -0.4013
Операционные расходы, млрд ¥
0.0494 0.1591 0.5009 0.4417 0.6072 0.6477 0.6477
CAPEX, млрд ¥
0.000334 0.000766 0.0502 0.6648 0.31 0.3619 0.3619


Balance sheet

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 LTM 5 year average CAGR 5
Наличность, млрд ¥
0.0256 0.1924 2.03 1.13 1.31 0.8428 0.8428
Short Term Investments ¥
0.0663 1.06 0.64 0.1184 0.2067 0.2067
Total Receivables ¥
0.0001 0.0136 0.0486 0.0444 0.1062 0.111 0.111
Total Current Assets ¥
0.093 1.26 2.1 1.83 1.46 1.21 1.21
Чистые активы, млрд ¥
0.0014 0.002 0.082 0.3659 0.4481 0.1731 1.58
Активы, млрд ¥
0.0946 1.29 2.6 3.33 3.04 3.27 3.27
Short Term Debt ¥
0.12 0.12
Long Term Debt ¥
0.8673 3.32 0.0058 0.0076 0.0173
Задолженность, млрд ¥
0.9157 3.36 0.0972 0.2229 0.295 0.351 0.351
Долг, млрд ¥
0.1032 0.3947 0.000631 0.0296
Interest income ¥
0 0.0001 0.0143 0.0139 0.0018 0.0219
Расходы на обслуживание долга ¥
0 0.0001 0.0001 0.000567 0.0519 0.0013 0.0013
Чист. проц. доходы, млрд ¥
0.0000 0.0038 0.0142 0.0263 0.0264 0.0206 0.024
Себестоимость, млрд ¥
0.0000 0.0017 0.0192 0.056 0.102 0.102
Товарно материальные запасы ¥
0.000259 0.003 0.005 0.0241 0.0325 0.0325


Share

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 LTM 5 year average CAGR 5
EPS -0.0429 -0.2713 -0.4557 -0.0464 -0.5846 -0.5497 -0.5497
Цена акции ао 27 17.5 9.81 6.68 5.4 5.4
Число акций ао, млн 613.76 575.25 591.14 666.74 688.74 690.9 690.9
FCF/акцию -0.0758 -0.1892 -0.8749 -1.29 -0.7414 -0.7813 -0.7813


Efficiency

IFRS
Reporting Annual Quarterly
2018 2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
ROE, % 25.28 63.44 -90.51 -8.36 -13.75 -13.4 -13.4 8.15
ROA, % -219.41 -101.75 -87.12 -7.81 -12.63 -12.03 -12.03 5.11
ROS, % -690690 -17294.33 -463.06 -253.3 -154.15 -154.15 -154.15 7.36
ROCE, % 7.23 7.68 -18.05 -12.42 -16.3 5.48
Рентаб EBITDA, % -696952.63 -17293.88 -462.05 -226.46 -226.46 6.06
Чистая рентаб, % -690690 -17294.33 -463.06 -253.3 -154.15 -154.15 7.37
Operation Margin, % -697588.42 -3724.99 -438.31 -251.91 -162.9 -162.9 -162.9 9.85
Доходность FCF, % -3.4 -5.86 -6.94 -9.15


Coefficients

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 LTM Industry average 5 year average CAGR 5
P/E
-6.72 -56.59 -18.27 -15.53 22.50
P/BV
6.08 4.73 2.07 1.44 1.44 2.99
P/S
1161.61 262.06 35.84 17.01 17.01 9.92
P/FCF
-29.41 -17.08 -14.41 -10.92 -11.82 -11.82 6.53
E/P
-0.1489 -0.0177 -0.0547 -0.0644 -0.0595 -0.0595 0.04
EV/EBITDA
-13.93 -5.04
EV/Ebit
0 0
EV/S
29.4 20.34 20.34 46.67
EV/FCF
-9.28 -9.28 16.03
Debt/EBITDA
-2.51 -0.0023 -0.0767 -0.0767 -0.0767 0.72
Netdebt/Ebitda
0 0 0 -0.64
Debt/Ratio
2.57 0.002 0.0091 0.009 0.009 0.10
Debt/Equity
-1.61 0.0021 0.0187 0.0187 0.0187 0.95
Debt/Net Income
-2.53 -0.0023 -0.0686 -0.0779 -0.0779 1.14
Бета
2.94 -0.4662 -0.4662 1.94
Индекс Альтмана
2 0.9174 0.9174 5.89


Dividends

IFRS
Reporting Annual
LTM Industry average 5 year average CAGR 5
Дивиденд
0
Див доход, ао, %
0 2.64
Дивиденды / прибыль, %
0 18.57


Pay for your subscription

More functionality and data for company and portfolio analysis is available by subscription

Subscribe

Other

IFRS
Reporting Annual Quarterly
2019 2020 2021 2022 2023 2024 CAGR 5
ebit_margin
-83656.84 -3449.28 -687.36 -286.78
Персонал, чел
398 444